Williams Rodney James 4
4 · Zomedica Pharmaceuticals Corp. · Filed Dec 27, 2018
Insider Transaction Report
Form 4
Williams Rodney James
Director
Transactions
- Exercise/Conversion
Common Shares, without par value
2018-12-20$1.20/sh+26,900$32,280→ 161,900 total - Exercise/Conversion
Stock Option (right to buy)
2018-12-20−26,900→ 0 totalExercise: $1.20From: 2016-12-21Exp: 2018-12-21→ Common Shares, without par value (200,000 underlying)
Holdings
- 40,000(indirect: By Trust)
Common Shares, without par value
Footnotes (1)
- [F1]The options vested upon grant.